Published in Cancer Weekly, December 9th, 1996
Announced jointly by all four companies, OraVax and Pasteur Merieux Connaught have licensed the complete genome sequence of Helicobacter pylori for the development of vaccines against H. pylori. H. pylori is the bacterium which causes the majority of cases of duodenal and stomach ulcers and is a major risk factor for stomach cancer.
Under the terms of the agreement, OraVax and Pasteur Merieux...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.